Aging and infertility in women: A committee opinion

Fertility and Sterility

Volumn 78, Issue 1, 2002, Pages 215-219

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; INHIBIN;

AGING; ARTIFICIAL INSEMINATION; CHROMATID ABERRATION; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HISTOLOGY; HUMAN; MALE FERTILITY; MENOPAUSE; MENSTRUAL CYCLE; MORPHOLOGY; OOCYTE DONATION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SPERM; SPERMATOZOON MOTILITY; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY; UTERUS DISEASE;

EID: 0036298620     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03212-0     Document Type: Article

References (46)

1. Age and infertility
2. Female fecundity as a function of age: Results of artifical insemination in 2193 nulliparous women with azoospermic husbands
3. The profound impact of patient age on pregnancy outcome after early detection of fetal cardiac activity
4. Effects of male age on semen quality and fertility: A review of the literature
5. Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause
6. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women
7. Aneuploidy in older women. Higher rates of aneuploidy in oocytes from older women
8. Aneuploidy 16 in human embryos increases significantly with maternal age
9. 2500 Outpatient diagnostic hysteroscopies
10. Aging of the human endometrium: A basic morphological and immunohistochemical study
11. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation
12. Prognostic value of day 3 estradiol on in vitro fertilization outcome
13. Evaluation of basal estradiol levels in assisted reproductive technology cycles
14. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization
15. Interinstitutional variability of follicle-stimulating hormone and estradiol levels
16. Prognostic assessment of female fecundity
17. Prediction of response to controlled ovarian hyperstimulation: A comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels
18. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population
19. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy
20. Basal follicle-stimulating hormone level is abetter predictor of in vitro fertilization performance than age
21. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age
22. Intercycle variability of day 3 follicle- stimulating hormone level and its effect on stimulation quality in in vitro fertilization
23. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels
24. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone
25. Inhibin-B as a test of ovarian reserve for infertile women
26. Use of the antral follicle count to predict the outcome of assisted reproductive technologies
27. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles
28. Childbearing beyond age 40: Pregnancy outcome in 24,032 cases
29. Rates of chromosome abnormalities at different maternal ages
30. Clomiphene citrate with intra-uterine insemination: Is it effective therapy in women above the age of 35 years?
31. Ovulation induction in women age 40 and older: The importance of basal follicle-stimulating hormone level and chronological age
32. Female and male partner age and menotrophin requirements influence pregnancy rates with human menopausal gonadotrophin therapy in combination with intrauterine insemination
33. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: Is it worthwhile?
34. Is there a role for ovarian stimulation and intrauterine insemination after age 40?
35. Intrauterine insemination: Evaluation of the results according to the woman's age, sperm quality, total sperm count per insemination and life table analysis
36. Sequential clomiphene citrate and human menopausal gondotrophin with intrauterine insemination: The effect of patient age on clinical outcome
37. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network
38. Reproductive outcome after sterilization reversal in women of advanced reproductive age
39. Outcome of assisted reproductive technology in women over the age of 41
40. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities
41. The age-related decline in female fecundity: A quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization
42. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization
43. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques
44. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos
45. In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer